Adeno-associated virus vectors for treatment of rett syndrome

TW202634069APending Publication Date: 2026-08-16STRIDEBIO INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114142684
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-08-19
Filing Date
2021-08-19
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001072898_001
    Figure TWG2TA001072898_001
  • Figure TWG2TA001072898_002
    Figure TWG2TA001072898_002
  • Figure TWG2TA001072898_003
    Figure TWG2TA001072898_003
Patent Text Reader

Abstract

The disclosure provides nucleic acids (comprising AAV expression cassettes), AAV vectors, and compositions for use in methods for treating and / or delaying the onset of diseases associated with mutations in the mecp2 gene, such as Rett Syndrome. Also, provided herein are methods for treating and / or delaying the onset of brain-derived neurotrophic factor (BDNF)-associated diseases.
Need to check novelty before this filing date? Find Prior Art